Study finds common breast cancer treatments may speed aging process

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Reduced screening rates and a higher prevalence of triple-negative breast cancer are driving elevated rates of advanced breast cancer in a geographic hotspot in Wilmington, Delaware, according to findings by researchers at ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute.

July 25, 2025

Vol.51 No.29

In Brief

University of Illinois Cancer Center awarded $709,000 from DOD breast cancer research program

University of Illinois Cancer Center investigators won a $709,000 grant award from the U.S. Department of Defense Breast Cancer Research Program.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Pre-clinical study finds link between metabolism and protective effect of breastfeeding against breast cancer

A mother’s mitochondria determines if lactation is protective or not against breast cancer—and points to a possible intervention to increase the benefit to more women, according to a pre-clinical study conducted by researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

July 18, 2025

Vol.51 No.28

In Brief

Arjan Gower receives NCCN grant to study a targeted therapy for early-stage NSCLC with rare EGFR mutations

Arjan Gower, a hematologist/oncologist at the UCLA Health Jonsson Comprehensive Cancer Center, received a $950,000 grant from the National Comprehensive Cancer Network and Taiho Oncology Inc. to help launch a multi-institutional clinical trial to test zipalertinib, an investigational drug that targets specific EGFR mutations, including Exon 20 insertions, which are known to drive cancer growth and resist standard treatments.

July 11, 2025

Vol.51 No.27

Clinical Roundup

Weight-associated breast cancer risk is higher in women with cardiovascular disease, IARC analysis shows

Excess weight is linked to an especially high risk of developing breast cancer in postmenopausal women with cardiovascular disease, according to research from the International Agency for Research on Cancer. The study was published in Cancer.

July 11, 2025

Vol.51 No.27

Clinical Roundup

Common autoimmune drug may help reverse immunotherapy-induced diabetes, UCLA preclinical study finds

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and even reverse, immune checkpoint inhibitor-induced type 1 diabetes using an existing class of autoimmune drugs.

July 11, 2025

Vol.51 No.27

Study finds common breast cancer treatments may speed aging process

YOU MAY BE INTERESTED IN

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

University of Illinois Cancer Center awarded $709,000 from DOD breast cancer research program

Pre-clinical study finds link between metabolism and protective effect of breastfeeding against breast cancer

Arjan Gower receives NCCN grant to study a targeted therapy for early-stage NSCLC with rare EGFR mutations

Weight-associated breast cancer risk is higher in women with cardiovascular disease, IARC analysis shows

Common autoimmune drug may help reverse immunotherapy-induced diabetes, UCLA preclinical study finds

Renew today!

Subscriber content

Never miss an issue!

Login